CHARACTERISTICS OF PATIENTS WITH EARLY RHEUMATOID ARTHRITIS WHO HAVE A DELAYED RESPONSE TO TREATMENT WITH METHOTREXATE IN MONOTHERAPY OR IN COMBINATION WITH ADALIMUMAB

被引：0
|
作者：
Smolen, J. [1 ]
Bu, X. [2 ]
Wang, X. [2 ]
Suboticki, J. [2 ]
Kavanaugh, A. [3 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] AbbVie Inc, N Chicago, IL USA
[3] Univ Calif San Diego, San Diego, CA 92103 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
PLUS METHOTREXATE; THERAPY; TRIAL;
D O I：
10.1136/annrheumdis-2018-eular.2635
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0121
引用
收藏
页码：605 / 605
页数：1
相关论文
共 50 条
  • [21] Beyond methotrexate monotherapy for early rheumatoid arthritis
    Scott, David L.
    [J]. LANCET, 2016, 388 (10042): : 309 - 310
  • [22] Increase in methotrexate dose in patients with rheumatoid arthritis who have an inadequate response to infliximab
    Ornetti, P
    Solau, E
    Gaudin, P
    Sibilia, J
    Berthelot, JM
    Puechal, X
    Tavernier, C
    Maillefert, JF
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (09) : 1379 - 1380
  • [23] Treating Rheumatoid Arthritis to Target: Outcomes and Predictors in Early Rheumatoid Arthritis Patients Treated with Adalimumab Plus Methotrexate, Methotrexate Alone, or Methotrexate Plus Subsequent Adalimumab
    Smolen, Josef
    Fleischmann, Roy M.
    Emery, Paul
    van Vollenhoven, Ronald F.
    Guerette, Benoit
    Santra, Sourav
    Kupper, Hartmut
    Redden, Laura
    Wolfe, Benjamin
    Kavanaugh, Arthur
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S665 - S665
  • [24] Adalimumab and methotrexate combination could improve disease control for early-stage rheumatoid arthritis patients
    不详
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (04) : 408 - 408
  • [25] Adalimumab and methotrexate combination could improve disease control for early-stage rheumatoid arthritis patients
    不详
    [J]. IMMUNOTHERAPY, 2011, 3 (08) : 924 - 924
  • [26] TREATING RHEUMATOID ARTHRITIS TO TARGET: OUTCOMES AND PREDICTORS IN EARLY RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ADALIMUMAB PLUS METHOTREXATE, METHOTREXATE ALONE OR METHOTREXATE PLUS SUBSEQUENT ADALIMUMAB
    Smolen, Josef S.
    Fleischmann, Roy M.
    Emery, Paul
    van Vollenhoven, Ronald F.
    Guerette, Benoit
    Santra, Sourav
    Kupper, Hartmut
    Redden, Laura
    Kavanaugh, Arthur
    [J]. RHEUMATOLOGY, 2012, 51 : 114 - 115
  • [27] The combination glucocorticoid-adalimumab-methotrexate as induction therapy in early aggressive rheumatoid arthritis
    Montecucco, Carlomaurizio
    Caporali, Roberto
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (05) : 829 - 829
  • [28] Sarilumab monotherapy vs sarilumab and methotrexate combination therapy in patients with rheumatoid arthritis
    Burmester, Gerd R.
    Bykerk, Vivian P.
    Buch, Maya H.
    Tanaka, Yoshiya
    Kameda, Hideto
    Praestgaard, Amy
    van Hoogstraten, Hubert
    Fernandez-Nebro, Antonio
    Huizinga, Thomas
    [J]. RHEUMATOLOGY, 2022, 61 (06) : 2596 - 2602
  • [29] Predicting the Need for Additional Treatment in Early Rheumatoid Arthritis Patients Treated to Target on Methotrexate Monotherapy
    Teitsma, Xavier
    Jacobs, Johannes
    Welsing, Paco
    Woodworth, Thasia
    Petho-Schramm, Attila
    Borm, Michelle
    Bernasconi, Corrado
    Lafeber, Floris
    Bijlsma, Johannes W. J.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [30] DIACEREIN IN COMBINATION WITH METHOTREXATE VERSUS METHOTREXATE ALONE IN THE TREATMENT OF EARLY RHEUMATOID ARTHRITIS
    Louthrenoo, W.
    Nilganuwong, S.
    Nanagara, R.
    Siripaitoon, B.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 262 - 262
12345